Update: 26.11.2024
Last week: 46 week 2024 (11.11.2024 - 17.11.2024)
Last full month: October 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 11 195 | 6.4% | 13.4% | 0.3 | 19 627 583 | 9.7% | 9.0% | 0.4 | 3.9% |
| MoM | 46 299 | 25.2% | 13.5% | 0.1 | 78 544 747 | 16.9% | 8.8% | -0.4 | 24.4% |
| YTD | 364 755 | 22.8% | 12.2% | 3.1 | 732 402 610 | 29.8% | 9.3% | 1.7 | -8.9% |
| MAT | 408 553 | 22.4% | 11.9% | 2.9 | 825 060 840 | 31.0% | 9.2% | 1.6 | -7.2% |
| BRAINMAX | |||||||||
| WoW | 3 165 | 10.7% | 100.0% | 0 | 10 404 329 | 11.0% | 100.0% | 0 | 10.7% |
| MoM | 11 465 | 51.5% | 100.0% | 0 | 38 983 593 | 47.0% | 100.0% | 0 | 51.5% |
| YTD | 68 372 | 74.7% | 100.0% | 0 | 238 166 768 | 77.6% | 100.0% | 0 | 74.7% |
| MAT | 75 881 | 77.2% | 100.0% | 0 | 265 086 457 | 81.8% | 100.0% | 0 | 77.2% |
| GOLDLINE PLUS | |||||||||
| WoW | 15 723 | 3.2% | 48.1% | 0.4 | 48 766 915 | 1.9% | 39.0% | -0.2 | 2.3% |
| MoM | 65 432 | 6.8% | 46.1% | 0.2 | 202 749 324 | 6.6% | 37.8% | 0.1 | 6.4% |
| YTD | 746 466 | -4.8% | 45.3% | 0.5 | 2 343 112 338 | -3.1% | 37.1% | -2.7 | -5.8% |
| MAT | 831 241 | -3.5% | 45.3% | 0.6 | 2 615 768 983 | -1.1% | 37.3% | -2.5 | -4.8% |
| MIGRENIUM | |||||||||
| WoW | 10 394 | 1.3% | 0.5% | 0 | 3 548 995 | 1.3% | 0.6% | 0 | 1.3% |
| MoM | 40 982 | -0.4% | 0.4% | 0 | 13 954 118 | 0.8% | 0.5% | 0 | 3.5% |
| YTD | 516 577 | -11.1% | 0.5% | -0.1 | 163 883 385 | 50.6% | 0.7% | 0.2 | 5.9% |
| MAT | 577 240 | -13.1% | 0.5% | -0.1 | 177 762 410 | 43.7% | 0.6% | 0.1 | 7.7% |
| MODELAX-N | |||||||||
| WoW | 28 654 | 0.7% | 20.9% | 0.3 | 14 239 847 | 1.1% | 14.1% | 0.3 | -0.7% |
| MoM | 119 788 | 11.4% | 20.1% | -0.5 | 57 090 549 | 12.1% | 13.2% | -0.3 | 13.9% |
| YTD | 1 302 587 | 25.9% | 22.1% | 3.1 | 578 180 417 | 73.5% | 14.3% | 3.8 | 8.0% |
| MAT | 1 436 066 | 27.8% | 21.4% | 3 | 627 829 810 | 72.8% | 13.7% | 3.4 | 9.8% |
| REDUXIN | |||||||||
| WoW | 9 994 | -1.1% | 30.6% | -1.1 | 53 955 506 | 1.1% | 43.2% | -0.6 | 2.3% |
| MoM | 46 001 | 7.6% | 32.4% | 0.4 | 237 476 007 | 7.9% | 44.3% | 0.6 | 6.4% |
| YTD | 539 262 | -7.1% | 32.7% | -0.4 | 2 861 755 365 | 11.0% | 45.3% | 2.9 | -5.8% |
| MAT | 596 702 | -6.4% | 32.6% | -0.6 | 3 156 828 338 | 12.6% | 45.0% | 2.8 | -4.8% |
| REDUXIN FORTE | |||||||||
| WoW | 3 246 | 5.6% | 9.9% | 0.3 | 13 810 383 | 9.2% | 11.1% | 0.7 | 2.3% |
| MoM | 13 965 | 1.4% | 9.8% | -0.5 | 59 017 541 | 0.1% | 11.0% | -0.7 | 6.4% |
| YTD | 150 528 | 1.0% | 9.1% | 0.6 | 647 149 543 | 11.6% | 10.2% | 0.7 | -5.8% |
| MAT | 167 560 | 2.0% | 9.1% | 0.6 | 720 879 272 | 13.1% | 10.3% | 0.7 | -4.8% |
| SALVISAR | |||||||||
| WoW | 16 330 | -0.4% | 2.1% | -0.1 | 7 259 739 | -0.3% | 1.9% | -0.1 | 2.7% |
| MoM | 58 452 | 22.5% | 1.7% | 0.2 | 25 561 706 | 25.4% | 1.5% | 0.2 | 8.1% |
| YTD | 491 379 | 10.0% | 1.4% | 0.2 | 204 741 666 | 39.4% | 1.3% | 0.2 | -3.0% |
| MAT | 542 920 | 2.0% | 1.4% | 0 | 221 623 441 | 25.6% | 1.2% | 0.1 | -1.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 364 755 | 22.8% | 12.2% | 3.1 | 732 402 610 | 29.8% | 9.3% | 1.7 | -8.9% |
| BRAINMAX | 68 372 | 74.7% | 100.0% | 0 | 238 166 768 | 77.6% | 100.0% | 0 | 74.7% |
| GOLDLINE PLUS | 746 466 | -4.8% | 45.3% | 0.5 | 2 343 112 338 | -3.1% | 37.1% | -2.7 | -5.8% |
| MIGRENIUM | 516 577 | -11.1% | 0.5% | -0.1 | 163 883 385 | 50.6% | 0.7% | 0.2 | 5.9% |
| MODELAX-N | 1 302 587 | 25.9% | 22.1% | 3.1 | 578 180 417 | 73.5% | 14.3% | 3.8 | 8.0% |
| REDUXIN CAPS | 539 262 | -7.1% | 32.7% | -0.4 | 2 861 755 365 | 11.0% | 45.3% | 2.9 | -5.8% |
| REDUXIN FORTE | 150 528 | 1.0% | 9.1% | 0.6 | 647 149 543 | 11.6% | 10.2% | 0.7 | -5.8% |
| SALVISAR | 491 379 | 10.0% | 1.4% | 0.2 | 204 741 666 | 39.4% | 1.3% | 0.2 | -3.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 408 553 | 22.4% | 11.9% | 2.9 | 825 060 840 | 31.0% | 9.2% | 1.6 | -7.2% |
| BRAINMAX | 75 881 | 77.2% | 100.0% | 0 | 265 086 457 | 81.8% | 100.0% | 0 | 77.2% |
| GOLDLINE PLUS | 831 241 | -3.5% | 45.3% | 0.6 | 2 615 768 983 | -1.1% | 37.3% | -2.5 | -4.8% |
| MIGRENIUM | 577 240 | -13.1% | 0.5% | -0.1 | 177 762 410 | 43.7% | 0.6% | 0.1 | 7.7% |
| MODELAX-N | 1 436 066 | 27.8% | 21.4% | 3 | 627 829 810 | 72.8% | 13.7% | 3.4 | 9.8% |
| REDUXIN CAPS | 596 702 | -6.4% | 32.6% | -0.6 | 3 156 828 338 | 12.6% | 45.0% | 2.8 | -4.8% |
| REDUXIN FORTE | 167 560 | 2.0% | 9.1% | 0.6 | 720 879 272 | 13.1% | 10.3% | 0.7 | -4.8% |
| SALVISAR | 542 920 | 2.0% | 1.4% | 0 | 221 623 441 | 25.6% | 1.2% | 0.1 | -1.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 11 195 | 6.4% | 13.4% | 0.3 | 19 627 583 | 9.7% | 9.0% | 0.4 | 3.9% |
| BRAINMAX | 3 165 | 10.7% | 100.0% | 0 | 10 404 329 | 11.0% | 100.0% | 0 | 10.7% |
| GOLDLINE PLUS | 15 723 | 3.2% | 48.1% | 0.4 | 48 766 915 | 1.9% | 39.0% | -0.2 | 2.3% |
| MIGRENIUM | 10 394 | 1.3% | 0.5% | 0 | 3 548 995 | 1.3% | 0.6% | 0 | 1.3% |
| MODELAX-N | 28 654 | 0.7% | 20.9% | 0.3 | 14 239 847 | 1.1% | 14.1% | 0.3 | -0.7% |
| REDUXIN CAPS | 9 994 | -1.1% | 30.6% | -1.1 | 53 955 506 | 1.1% | 43.2% | -0.6 | 2.3% |
| REDUXIN FORTE | 3 246 | 5.6% | 9.9% | 0.3 | 13 810 383 | 9.2% | 11.1% | 0.7 | 2.3% |
| SALVISAR | 16 330 | -0.4% | 2.1% | -0.1 | 7 259 739 | -0.3% | 1.9% | -0.1 | 2.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 46 299 | 25.2% | 13.5% | 0.1 | 78 544 747 | 16.9% | 8.8% | -0.4 | 24.4% |
| BRAINMAX | 11 465 | 51.5% | 100.0% | 0 | 38 983 593 | 47.0% | 100.0% | 0 | 51.5% |
| GOLDLINE PLUS | 65 432 | 6.8% | 46.1% | 0.2 | 202 749 324 | 6.6% | 37.8% | 0.1 | 6.4% |
| MIGRENIUM | 40 982 | -0.4% | 0.4% | 0 | 13 954 118 | 0.8% | 0.5% | 0 | 3.5% |
| MODELAX-N | 119 788 | 11.4% | 20.1% | -0.5 | 57 090 549 | 12.1% | 13.2% | -0.3 | 13.9% |
| REDUXIN CAPS | 46 001 | 7.6% | 32.4% | 0.4 | 237 476 007 | 7.9% | 44.3% | 0.6 | 6.4% |
| REDUXIN FORTE | 13 965 | 1.4% | 9.8% | -0.5 | 59 017 541 | 0.1% | 11.0% | -0.7 | 6.4% |
| SALVISAR | 58 452 | 22.5% | 1.7% | 0.2 | 25 561 706 | 25.4% | 1.5% | 0.2 | 8.1% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
*****
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs